Form 4 for FATE FATE THERAPEUTICS INC
Accepted 2023-01-13 00:00:00 ET · period of report 2023-01-11 · accession 0001209191-23-003338 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-01-13 | 2023-01-11+ | FATE | MENDLEIN JOHN | Dir | P - Purchase | $5.60 | +124.7K | 246.1K | +103% | +$698.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-01-13 | P | A | 36,631 | $5.43 | 282,770 | D | — | — | |
| 2 | Common | Common Stock | 2023-01-11 | P | A | 88,048 | $5.67 | 246,139 | D | — | — |